Home6919 • TPE
add
Caliway Biopharmaceuticals Co Ltd
Previous close
$626.00
Day range
$622.00 - $647.00
Year range
$436.00 - $668.00
Market cap
98.35B TWD
Avg Volume
1.06M
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
| (TWD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 23.26M | 164.43% |
Operating expense | 169.15M | 26.26% |
Net income | -137.57M | -26.21% |
Net profit margin | -591.52 | 52.27% |
Earnings per share | -0.99 | — |
EBITDA | -147.66M | -20.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (TWD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.69B | — |
Total assets | 9.80B | — |
Total liabilities | 70.23M | — |
Total equity | 9.73B | — |
Shares outstanding | 153.44M | — |
Price to book | 9.87 | — |
Return on assets | -5.78% | — |
Return on capital | -5.84% | — |
Cash Flow
Net change in cash
| (TWD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -137.57M | -26.21% |
Cash from operations | -119.47M | -80.31% |
Cash from investing | 19.18M | 306.83% |
Cash from financing | 6.48B | 314,315.14% |
Net change in cash | 6.38B | 10,156.01% |
Free cash flow | -114.67M | — |
About
Founded
2012
Website
